Oncogenic B-RAF Signaling in Melanoma Impairs the Therapeutic Advantage of Autophagy Inhibition
Jane L. Armstrong(University of Sunderland), Penny E. Lovat(NIHR Newcastle Biomedical Research Centre)
Cited by 65
Related Papers
Increasing Melanoma Cell Death Using Inhibitors of Protein Disulfide Isomerases to Abrogate Survival Responses to Endoplasmic Reticulum Stress
|Cancer Research|2008|174
NFAT signalling is a novel target of oncogenic BRAF in metastatic melanoma
|British Journal of Cancer|2009|71
Inhibition of CXCR4–CXCL12 chemotaxis in melanoma by AMD11070
|British Journal of Cancer|2013|63
Melanoma secretion of transforming growth factor‐β2 leads to loss of epidermal AMBRA1 threatening epidermal integrity and facilitating tumour ulceration*
|British Journal of Dermatology|2021|16